It's data from the same study.
With the same flaws.
FDA wanted another study. They got post hoc analysis, comparison with some secondary bio markers, etc.
Cell Therapy News/Articles, page-16469
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.050(4.46%) |
Mkt cap ! $1.224B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $7.789M | 7.239M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 56049 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 39938 | 7 |
View Market Depth
| Last trade - 12.02pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |